It is common practice for developers of new health care technologies to engage in early dialogue with the major regulatory agencies; such discussions frequently center around the proposed clinical trial designs to support the registration of new interventions and suggestions on their improvement. Pr...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!